Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
DGX — Quest Diagnostics Incorporated
NYSE
FULL STOCK PAGE →

Q4 2025 Earnings Call Summary

FEB 10, 2026
REVENUE
$2.81B -0.4%
NET MARGIN
8.7% 0.0 PTS
EPS
$2.21 +1.4%
FREE CASH FLOW
$307.0M -26.7%

No summary has been written for this call yet.